Ciprofloxacin Drug Interactions
84Total Interactions
36Severe
45Moderate
2Mild
| Drug | Severity | Summary |
|---|---|---|
| Aceclofenac | SEVERE | Aceclofenac potentially increases the risk of seizures when given with Ciprofloxacin. Manufacture... |
| Acenocoumarol | SEVERE | Ciprofloxacin increases the anticoagulant effect of Acenocoumarol. Manufacturer advises monitor INR. |
| Benzydamine | SEVERE | Benzydamine potentially increases the risk of seizures when given with Ciprofloxacin. Manufacture... |
| Bromfenac | SEVERE | Bromfenac potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Celecoxib | SEVERE | Celecoxib potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Clozapine | SEVERE | Ciprofloxacin increases the concentration of Clozapine. Manufacturer advises monitor adverse effe... |
| Dexketoprofen | SEVERE | Dexketoprofen potentially increases the risk of seizures when given with Ciprofloxacin. Manufactu... |
| Diclofenac | SEVERE | Diclofenac potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer... |
| Elacestrant | SEVERE | Ciprofloxacin is predicted to increase the exposure to Elacestrant. Manufacturer advises avoid or... |
| Eliglustat | SEVERE | Ciprofloxacin is predicted to increase the exposure to Eliglustat. Manufacturer advises avoid or ... |
| Etodolac | SEVERE | Etodolac potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer a... |
| Etoricoxib | SEVERE | Etoricoxib potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer... |
| Flurbiprofen | SEVERE | Flurbiprofen potentially increases the risk of seizures when given with Ciprofloxacin. Manufactur... |
| Fosphenytoin | SEVERE | Ciprofloxacin affects the concentration of Fosphenytoin. Manufacturer advises monitor concentrati... |
| Ibrutinib | SEVERE | Ciprofloxacin is predicted to increase the exposure to Ibrutinib. Manufacturer advises adjust dos... |
| Ibuprofen | SEVERE | Ibuprofen potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Indometacin | SEVERE | Indometacin potentially increases the risk of seizures when given with Ciprofloxacin. Manufacture... |
| Ketoprofen | SEVERE | Ketoprofen potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer... |
| Ketorolac | SEVERE | Ketorolac potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Mefenamic acid | SEVERE | Mefenamic acid potentially increases the risk of seizures when given with Ciprofloxacin. Manufact... |
| Meloxicam | SEVERE | Meloxicam potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Methotrexate | SEVERE | Ciprofloxacin potentially increases the risk of toxicity when given with Methotrexate. Manufactur... |
| Nabumetone | SEVERE | Nabumetone potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer... |
| Naproxen | SEVERE | Naproxen potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer a... |
| Nepafenac | SEVERE | Nepafenac potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Parecoxib | SEVERE | Parecoxib potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Phenazone | SEVERE | Phenazone potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Phenytoin | SEVERE | Ciprofloxacin affects the concentration of Phenytoin. Manufacturer advises monitor concentration ... |
| Piroxicam | SEVERE | Piroxicam potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Sulindac | SEVERE | Sulindac potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer a... |
| Tenoxicam | SEVERE | Tenoxicam potentially increases the risk of seizures when given with Ciprofloxacin. Manufacturer ... |
| Tiaprofenic acid | SEVERE | Tiaprofenic acid potentially increases the risk of seizures when given with Ciprofloxacin. Manufa... |
| Tolfenamic acid | SEVERE | Tolfenamic acid potentially increases the risk of seizures when given with Ciprofloxacin. Manufac... |
| Venetoclax | SEVERE | Ciprofloxacin is predicted to increase the exposure to Venetoclax. Manufacturer advises avoid or ... |
| Warfarin | SEVERE | Ciprofloxacin increases the anticoagulant effect of Warfarin. Manufacturer advises monitor INR. |
| Zanubrutinib | SEVERE | Ciprofloxacin is predicted to increase the exposure to Zanubrutinib. Manufacturer advises avoid o... |
| Agomelatine | MODERATE | Ciprofloxacin is predicted to increase the exposure to Agomelatine. Manufacturer advises caution. |
| Aminophylline | MODERATE | Ciprofloxacin is predicted to increase the exposure to Aminophylline. Manufacturer advises adjust... |
| Anagrelide | MODERATE | Ciprofloxacin is predicted to increase the exposure to Anagrelide. Manufacturer makes no recommen... |
| Antacids | MODERATE | oral Antacids decrease the absorption of oral Ciprofloxacin. Manufacturer advises take 2 hours be... |
| Calcium acetate | MODERATE | oral Calcium acetate decreases the absorption of oral Ciprofloxacin. Manufacturer advises separat... |
| Calcium carbonate | MODERATE | oral Calcium carbonate decreases the absorption of oral Ciprofloxacin. Manufacturer advises separ... |
| Calcium chloride | MODERATE | oral Calcium chloride decreases the absorption of oral Ciprofloxacin. Manufacturer advises separa... |
| Calcium gluconate | MODERATE | oral Calcium gluconate decreases the absorption of oral Ciprofloxacin. Manufacturer advises separ... |
| Calcium lactate | MODERATE | oral Calcium lactate decreases the absorption of oral Ciprofloxacin. Manufacturer advises separat... |
| Calcium phosphate | MODERATE | oral Calcium phosphate decreases the absorption of oral Ciprofloxacin. Manufacturer advises separ... |
| Capivasertib | MODERATE | Ciprofloxacin is predicted to increase the exposure to Capivasertib. Manufacturer advises adjust ... |
| Chlorpromazine | MODERATE | Ciprofloxacin is predicted to increase the exposure to Chlorpromazine. Manufacturer makes no reco... |
| Daridorexant | MODERATE | Ciprofloxacin is predicted to increase the exposure to Daridorexant. Manufacturer advises adjust ... |
| Duloxetine | MODERATE | Ciprofloxacin is predicted to increase the exposure to Duloxetine. Manufacturer advises avoid. |
| Enteral feeds | MODERATE | Enteral feeds decrease the exposure to Ciprofloxacin. Manufacturer makes no recommendation. |
| Erlotinib | MODERATE | Ciprofloxacin are predicted to increases the exposure to Erlotinib. Manufacturer advises monitor ... |
| Fezolinetant | MODERATE | Ciprofloxacin is predicted to increase the exposure to Fezolinetant. Manufacturer advises avoid. |
| Guanfacine | MODERATE | Ciprofloxacin is predicted to increase the concentration of Guanfacine. Manufacturer advises adju... |
| Iron | MODERATE | oral Iron decreases the exposure to oral Ciprofloxacin. Manufacturer advises separate administrat... |
| Lanthanum | MODERATE | Lanthanum moderately decreases the exposure to Ciprofloxacin. Manufacturer advises Ciprofloxacin ... |
| Leflunomide | MODERATE | Leflunomide is predicted to increase the exposure to Ciprofloxacin. Manufacturer advises caution. |
| Melatonin | MODERATE | Ciprofloxacin is predicted to increase the exposure to Melatonin. Manufacturer advises caution. |
| Nitisinone | MODERATE | Nitisinone is predicted to increase the exposure to Ciprofloxacin. Manufacturer makes no recommen... |
| Olanzapine | MODERATE | Ciprofloxacin is predicted to increase the exposure to Olanzapine. Manufacturer advises adjust dose. |
| Omaveloxolone | MODERATE | Ciprofloxacin is predicted to increase the exposure to Omaveloxolone. Manufacturer advises avoid ... |
| Pentoxifylline | MODERATE | Ciprofloxacin very slightly increases the exposure to Pentoxifylline. Manufacturer advises monito... |
| Pirfenidone | MODERATE | Ciprofloxacin is predicted to increase the exposure to Pirfenidone. Manufacturer advises use with... |
| Pomalidomide | MODERATE | Ciprofloxacin is predicted to increase the exposure to Pomalidomide. Manufacturer advises adjust ... |
| Rasagiline | MODERATE | Ciprofloxacin slightly increases the exposure to Rasagiline. Manufacturer advises caution. |
| Riluzole | MODERATE | Ciprofloxacin is predicted to increase the exposure to Riluzole. Manufacturer makes no recommenda... |
| Roflumilast | MODERATE | Ciprofloxacin is predicted to increase the exposure to Roflumilast. Manufacturer makes no recomme... |
| Ropinirole | MODERATE | Ciprofloxacin is predicted to increase the exposure to Ropinirole. Manufacturer advises adjust dose. |
| Ropivacaine | MODERATE | Ciprofloxacin is predicted to increase the exposure to Ropivacaine. Manufacturer makes no recomme... |
| Ruxolitinib | MODERATE | Ciprofloxacin is predicted to increase the exposure to Ruxolitinib. Manufacturer advises monitor ... |
| Sildenafil | MODERATE | Ciprofloxacin moderately increases the exposure to Sildenafil. Manufacturer advises caution. |
| Strontium | MODERATE | Strontium is predicted to decrease the absorption of Ciprofloxacin. Manufacturer advises avoid. |
| Sucralfate | MODERATE | Sucralfate decreases the exposure to Ciprofloxacin. Manufacturer advises separate administration ... |
| Teriflunomide | MODERATE | Teriflunomide is predicted to increase the exposure to Ciprofloxacin. Manufacturer advises caution. |
| Theophylline | MODERATE | Ciprofloxacin is predicted to increase the exposure to Theophylline. Manufacturer advises monitor... |
| Tizanidine | MODERATE | Ciprofloxacin increases the exposure to Tizanidine. Manufacturer advises avoid. |
| Tolvaptan | MODERATE | Ciprofloxacin is predicted to increase the exposure to Tolvaptan. Manufacturer advises use with c... |
| Vadadustat | MODERATE | Vadadustat is predicted to increase the exposure to Ciprofloxacin. Manufacturer advises monitor a... |
| Vorasidenib | MODERATE | Ciprofloxacin moderately increases the exposure to Vorasidenib. Manufacturer advises avoid. |
| Zinc | MODERATE | Zinc is predicted to decrease the exposure to Ciprofloxacin. Manufacturer advises separate admini... |
| Zolmitriptan | MODERATE | Ciprofloxacin is predicted to increase the exposure to Zolmitriptan. Manufacturer advises adjust ... |
| Bedaquiline | MILD | Ciprofloxacin might increase the exposure to Bedaquiline. Manufacturer makes no recommendation. |
| Lidocaine | MILD | Ciprofloxacin slightly increases the exposure to Lidocaine. Manufacturer makes no recommendation. |
| Loxapine | UNKNOWN | Ciprofloxacin is predicted to increase the exposure to Loxapine. Manufacturer advises avoid. |
Check Ciprofloxacin against your patient's full medication list
InteractRx checks all drug combinations at once — built for GP surgery pharmacists.
Use the Free Checker